PRESS RELEASE - February 14, 2007

CAVIT SCIENCES, INC. AND AMERICARE NUTRITIONAL DIVISION ANNOUNCE ASSET PURCHASE & ROYALTY AGREEMENT TO COMMERCIALIZE FOOD SUPPLEMENT AND HERBAL LINE

Contact: Colm King
561-544 6988
info@cavitsciences.com

www.CavitSciences.com

Delray Beach, FL, February 14, 2007—Cavit Sciences, Inc. ("Cavit") (OTCBB: CVIT) and Daycon Investors Associates, Inc., Americare Nutritional Division ("Americare") today announced the signing of an agreement enabling Cavit to commercialize a complete food supplement and herbal line for the enhancement of health.

Under the Asset Purchase & Royalty Agreement, Cavit has obtained the ingredients, combinations and proprietary formulations which have beneficial effects upon certain body conditions, including, but not limited to; heart disease, cancer, diabetes, obesity, hypertension, stress, arterial buildup, cardiovascular diseases, menopausal symptoms and cholesterol.

Cavit will introduce a full line of products to improve physical and psychological well-being, enhance the immune system, improve memory, act as antioxidants, increase energy and maintain a healthy nervous system. Cavit intends to manufacture, market, distribute and commercialize a range of supplements to act as powerful antioxidants and immune enhancers which have beneficial effects upon many serious diseases.

Cavit has agreed to pay Americare $250,000, which includes the knowledge and expertise of Dr. Joseph P. D'Angelo in developing and commercializing new products. Americare is also entitled to receive additional payments consisting of royalties upon commercial launch of each product and on net sales.

For additional information about this udpate, please visit www.CavitSciences.com.

About Cavit Sciences - Cavit Sciences, Inc. (“Cavit”) is a biotechnology company that has three developed supplement lines with products that enhance, improve, maintain and support the body by beneficially affecting various conditions and is engaged in developing treatments and prevention for cancer, viral infections, opportunistic infections, related diseases and the immune system. New product information and updates will continue to be added to Cavit’s website.

- END -

© 2007 Cavit Sciences